Overview
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects
Status:
Completed
Completed
Trial end date:
2019-12-01
2019-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study was a single-arm trial to obtain preliminary data on the efficacy of collagen membranes impregnated with recombinant human fibroblast growth factor (rhFGF-2) in the treatment of Miller's class I and class II gingival recessions.Phase:
Early Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
SVS Institute of Dental Sciences
Criteria
Inclusion Criteria:- systemically healthy subjects between 20-55 years presenting with Miller's class I or
class II gingival recession[
Exclusion Criteria:
- 1. Recessions associated with root demineralization/caries, deep cervical abrasion or
pulpal pathology, 2. Patients with history of systemic conditions affecting
periodontium and, 3. Smokers.